A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adult...

Por Pierce D, Corcoran M, Velinova M, Hossack S, Hoppenbrouwers M, Martin P
Publicado em 2015-02-01

Randomized clinical trial: effect of the 5-HT(4) receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

Por Tack, J, Zerbib, F, Blondeau, K, des Varannes, S B, Piessevaux, H, Borovicka, J, Mion, F, Fox, M, Bredenoord, A J, Louis, H, Dedrie, S, Hoppenbrouwers, M, Meulemans, A, Rykx, A, Thielemans, L, Ruth, M
Publicado no Neurogastroenterol Motil (2015)